If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis

October 03, 2011

More Lupus Nephritis Clinical Trials

Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis (hUC-MSC-SLE)
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients

More in Lupus Nephritis Clinical Trials:

Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Nephritis

RENAL & UROLOGY NEWS SITEMAP

Nephrology

Acute Renal Failure
Anemia
Chronic Kidney Disease
Contrast Nephropathy
Cardiovascular Disease
Diabetes
Diabetic Nephropathy
Focal Segmental Glomerulosclerosis
Hemodialysis
Hypertension
Kidney Cancer
Kidney Stones
Lupus Nephritis
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation

Jobs

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions

A Study of the Safety and Efficacy of an Interleukin-6 Inhibitor in Patients With Lupus Nephritis

More Lupus Nephritis Clinical Trials

RENAL & UROLOGY NEWS SITEMAP

News

Departments

More

Nephrology

Jobs

Urology

Archives

Other Haymarket Medical Websites

International